Medicina familiar y comunitaria
Especialidad
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (16)
2024
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Diferencias de sexo en los beneficios de la anticoagulación en pacientes ancianos con fibrilación auricular: un subanálisis del estudio EMERG-AF
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 35, Núm. 4, pp. 252-260
-
Impact of fragility fractures in postmenopausal Spanish women with osteoporosis
Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 4, pp. 135-143
2022
-
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
eClinicalMedicine, Vol. 51
-
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
eClinicalMedicine, Vol. 50
-
Modelo asistencial ambulatorio de alta resolución COVID-A2R: una solución efectiva en el servicio de urgencias para pacientes con COVID-19 y riesgo de evolución desfavorable
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 34, Núm. 2, pp. 111-118
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Association between acute heart failure and major cardiovascular events in atrial fibrillation patients presenting at the emergency department: An EMERG-AF ancillary study
European Journal of Emergency Medicine, Vol. 28, Núm. 3, pp. 210-217
-
Factors associated with poor prognosis in patients with atrial fibrillation: An emergency department perspective the EMERG-AF study
American Journal of Emergency Medicine, Vol. 50, pp. 270-277
-
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
The Lancet, Vol. 398, Núm. 10295, pp. 121-130
-
Socio-Demographic Health Determinants Are Associated with Poor Prognosis in Spanish Patients Hospitalized with COVID-19
Journal of General Internal Medicine, Vol. 36, Núm. 12, pp. 3737-3742
2019
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
-
Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries
Osteoporosis International, Vol. 30, Núm. 6, pp. 1243-1254
2018
-
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
PLoS ONE, Vol. 13, Núm. 6